Analyses routine frontal X-rays (chest, thoracic or lumbar spine, pelvis, knee, hand/wrist) of patients aged 50 and over to flag possible low bone density at the hip or lumbar spine. It is a pre-screening aid for radiologists, not a diagnosis, and must not be used to rule out low bone density.
Listed in the FDA AI-Enabled Medical Devices list (1 device(s), latest decision 2024, FDA panel: Radiology). Exact clearance number(s) to be confirmed.
Auriat et al., JBMR Plus 2025, retrospective single-centre study in Ottawa, 4,878 patients with DXA: AUC 0.84 for low bone density and 0.82 for osteoporosis; at a score cut-off of 7, sensitivity was 60% and specificity 87% for low bone density (vendor supplied the software only).
DICOM routing from PACS, result returned as a new PACS series; optional HL7 output to dictation systems (vendor-claimed)
– Pre-screening aid only: it does not diagnose osteoporosis, replace DXA or rule out low bone density.
– At a high-specificity cut-off, about 4 in 10 patients with low bone density were missed (Ottawa study).
– Most studies are by vendor authors; one independent validation, single-centre and retrospective.
– No published data on fracture outcomes, cost-effectiveness or European patients.
– For patients aged 50 and over only; US and international versions report different outputs.
This profile is not medical advice or an endorsement. Hospitals should perform their own due diligence (regulatory compliance, GDPR, cybersecurity, integration, local clinical validation). How we evaluate
Every profile documents the precise indication, regulatory status, vendor-supported and independent evidence, real-world deployment, limits and dated sources.
A independent systematic review or prospective multicentre study · B at least one independent peer-reviewed study · C peer-reviewed, vendor-supported · D vendor claims only.
Vendors, authors and clinicians can request a correction. Corrections are dated on the profile.
